Stop using nowDrug recall · FDA · Published June 13, 2020
Yusef Tropical Lip Moisturizer SPF 30 Recall: Superpotent Drug Risk
Yusef recalls Tropical Lip Moisturizer SPF 30 due to potential superpotent drug levels in some batches. This may cause serious health effects if used as intended.
“Yusef Tropical Lip Moisturizer SPF 30 Recall: Superpotent Drug Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37047-yusef-tropical-lip-moisturizer-spf-30-recall-superpotent-drug-risk. Based on FDA recall #D-1486-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1486-2020%22&limit=1).
The FDA announced on June 13, 2020, that Yusef Manufacturing Laboratories, LLC voluntarily recalled Tropical Lip Moisturizer, SPF 30 due to superpotent Meradimate levels. The agency issued recall number D-1486-2020 for the Class II violation.
The beginning portion of the batch appears to be approximately 25% superpotent for active ingredient Meradimate. The product contains Oxybenzone 5%, Octisalate 5%, Octinoxate 7.5%, and Meradimate 5%.
Context
GovInfoNow's records show Yusef Manufacturing Laboratories, LLC has two other recalls on record since March 3, 2020. On June 3, 2020, the company recalled Rocky Mountain Sunscreen SPF30 Lip Balm due to high Octisalate content risk. On March 3, 2020, Yusef recalled PEPPERMINT LIP MOISTURIZER for high Oxybenzone content risk. Other recent recalls of similar products include Medline Silicone Cream Recall (June 11, 2026), Sun Pharmaceutical Fluocinolone Acetonide Solution Recall (Dec. 30, 2025), and CoValence Laboratories Skin Rehab Gel Recall (March 18, 2026).
How to tell if you have this one
Check for the lot number 12750 on the product label. The product was made in the USA and expires May 2021.
Brand
Yusef
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop Using Now
Immediately stop using the recalled lip moisturizer as it may cause serious health effects.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3.7 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1486-2020 (June 13, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1486-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.